Vaccinogen Inc. | Key People and Executives
Andrew L. Tussing
Chairman, President & Chief Executive Officer
Michael G. Hanna
Chairman-Emeritus
Michael Hagerman
Director
Hakan S. Edstrom
Director
Anders Halldin
Vice Chairman
Andrew L. Tussing
Chairman, President & Chief Executive Officer
Peter Morsing
Chief Operating Officer
Rachel L. Hoover
Director-Clinical Operations
Dinand van der Linde
Managing Director-Business Development
Michael G. Hanna
Chairman-Emeritus
Michael Hagerman
Director
Hakan S. Edstrom
Director
Anders Halldin
Vice Chairman
Address |
949 Fell Street Baltimore Maryland 21231 United States
|
Employees
|
- |
Website |
http://www.vaccinogeninc.com |
Updated |
09/14/2018 |
Vaccinogen, Inc. is an immunotherapy company. The company engages in the development and commercialization of vaccines and immunotherapeutic products for cancer. Its primary product, OncoVAX is a vaccine for post-surgical treatment of stage II colon cancer. |